{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:19:26Z","timestamp":1789676366837,"version":"4.0.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011490","name":"Yangling Demonstration Area Science and Technology Bureau","doi-asserted-by":"publisher","award":["20242024SF-07"],"award-info":[{"award-number":["20242024SF-07"]}],"id":[{"id":"10.13039\/501100011490","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015401","name":"Key Research and Development Projects of Shaanxi Province","doi-asserted-by":"publisher","award":["2024CY-JJQ-42"],"award-info":[{"award-number":["2024CY-JJQ-42"]}],"id":[{"id":"10.13039\/501100015401","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015790","name":"ningxia huizu zizhiqu jiaoyuting","doi-asserted-by":"publisher","award":["2022ZDYF0410"],"award-info":[{"award-number":["2022ZDYF0410"]}],"id":[{"id":"10.13039\/100015790","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.toxicon.2025.108651","type":"journal-article","created":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T05:49:27Z","timestamp":1763185767000},"page":"108651","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Paeoniflorin suppresses non-small cell lung cancer by interrupting FGF2-FGFR2-PI3K axis"],"prefix":"10.1016","volume":"269","author":[{"given":"Xuexue","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bojiao","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Shahen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxicon.2025.108651_bib1","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1002\/1873-3468.13462","article-title":"A time-resolved live cell imaging assay to identify small molecule inhibitors of FGF2 signaling","volume":"593","author":"Ahmed","year":"2019","journal-title":"FEBS Lett."},{"key":"10.1016\/j.toxicon.2025.108651_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216349","article-title":"Spatial distribution and functional relevance of FGFR1 and FGFR2 expression for glioblastoma tumor invasion","volume":"571","author":"Alshahrany","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.toxicon.2025.108651_bib3","doi-asserted-by":"crossref","first-page":"6014","DOI":"10.1158\/1078-0432.CCR-08-0167","article-title":"Immunohistochemical expression of basic fibroblast growth factor and fibroblast growth factor receptors 1 and 2 in the pathogenesis of lung cancer","volume":"14","author":"Behrens","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.toxicon.2025.108651_bib4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/17425255.2022.2039118","article-title":"Fibroblast growth factor receptor (FGFR) inhibitors in cholangiocarcinoma: current status, insight on resistance mechanisms and toxicity management","volume":"18","author":"Chakrabarti","year":"2022","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.toxicon.2025.108651_bib5","first-page":"1","article-title":"Multispecific antibodies targeting PD-1\/PD-L1 in cancer","author":"Chen","year":"2025","journal-title":"BioDrugs"},{"key":"10.1016\/j.toxicon.2025.108651_bib6","doi-asserted-by":"crossref","first-page":"5681","DOI":"10.3390\/cancers13225681","article-title":"Biological significance and targeting of the FGFR axis in cancer","volume":"13","author":"Chioni","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.toxicon.2025.108651_bib7","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1146\/annurev-biochem-062917-012837","article-title":"Horizontal cell biology: monitoring global changes of protein interaction states with the proteome-wide cellular thermal shift assay (CETSA)","volume":"88","author":"Dai","year":"2019","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.toxicon.2025.108651_bib8","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1158\/2159-8290.CD-12-0362","article-title":"Fibroblast growth factor receptor inhibitors as a cancer treatment: from a biologic rationale to medical perspectives","volume":"3","author":"Dieci","year":"2013","journal-title":"Cancer Discov."},{"key":"10.1016\/j.toxicon.2025.108651_bib9","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.3390\/biom14121622","article-title":"Decoding FGF\/FGFR signaling: insights into biological functions and disease relevance","volume":"14","author":"Edirisinghe","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.toxicon.2025.108651_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110820","article-title":"Anti-tumor activities and mechanisms of Traditional Chinese medicines formulas: a review","volume":"132","author":"Fan","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.toxicon.2025.108651_bib11","first-page":"1","article-title":"Annexin A1 mRNA-loaded liposomes alleviate acute pancreatitis by suppressing STING pathway and promoting efferocytosis in macrophages","author":"Fang","year":"2025","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.toxicon.2025.108651_bib12","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3892\/ol.2024.14601","article-title":"Myeloid\/Lymphoid neoplasms with eosinophilia and FGFR1 rearrangement t (8; 13)(p11; q12): a case report and literature review","volume":"28","author":"Guo","year":"2024","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.toxicon.2025.108651_bib13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41572-024-00551-9","article-title":"Non-small-cell lung cancer","volume":"10","author":"Hendriks","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.toxicon.2025.108651_bib14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0140-6736(16)30958-8","article-title":"Lung cancer: current therapies and new targeted treatments","volume":"389","author":"Hirsch","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.toxicon.2025.108651_bib15","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2017-CT094","article-title":"Abstract CT094: phase I study of fibroblast growth factor receptor 2 antibody-drug conjugate (FGFR2-ADC) BAY 1187982 in patients with advanced cancer","volume":"77","author":"Kim","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.toxicon.2025.108651_bib16","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1111\/j.1349-7006.2008.00891.x","article-title":"Phosphatidylinositol 3-kinase inhibitors: promising drug candidates for cancer therapy","volume":"99","author":"Kong","year":"2008","journal-title":"Cancer Sci."},{"key":"10.1016\/j.toxicon.2025.108651_bib17","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s10555-021-10012-4","article-title":"Progression and metastasis of small cell lung carcinoma: the role of the PI3K\/Akt\/mTOR pathway and metabolic alterations","volume":"40","author":"Krencz","year":"2021","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.toxicon.2025.108651_bib18","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.3390\/ijms25063178","article-title":"PI3K\/Akt\/mTOR signaling pathway as a target for colorectal cancer treatment","volume":"25","author":"Leiphrakpam","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.toxicon.2025.108651_bib19","first-page":"561","volume":"vol. 6","author":"Liu","year":"2015"},{"key":"10.1016\/j.toxicon.2025.108651_bib20","first-page":"1572","article-title":"Investigation of uridine in anti-aging-related diseases based on network pharmacology, molecular docking and cell experimental validation","volume":"35","author":"Ma","year":"2025","journal-title":"Engineered Science"},{"key":"10.1016\/j.toxicon.2025.108651_bib21","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3389\/fphar.2020.00531","article-title":"Paeoniflorin, a natural product with multiple targets in liver Diseases-A mini review","volume":"11","author":"Ma","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.toxicon.2025.108651_bib22","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1242\/dev.152587","article-title":"Fibroblast growth factors: key players in regeneration and tissue repair","volume":"144","author":"Maddaluno","year":"2017","journal-title":"Development"},{"key":"10.1016\/j.toxicon.2025.108651_bib23","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1002\/cncr.35423","article-title":"Top advances of the year: targeted therapy for lung cancer","volume":"130","author":"Makarem","year":"2024","journal-title":"Cancer"},{"key":"10.1016\/j.toxicon.2025.108651_bib24","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1124\/mol.108.049544","article-title":"Fibroblast growth factor (FGF) and FGF receptor-mediated autocrine signaling in non-small-cell lung cancer cells","volume":"75","author":"Marek","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.toxicon.2025.108651_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/nano10040612","article-title":"Internalized FGF-2-Loaded nanoparticles increase nuclear ERK1\/2 content and result in lung cancer cell death","volume":"10","author":"Miao","year":"2020","journal-title":"Nanomaterials"},{"key":"10.1016\/j.toxicon.2025.108651_bib26","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s10120-021-01235-z","article-title":"The beginning of the era of precision medicine for gastric cancer with fibroblast growth factor receptor 2 aberration","volume":"24","author":"Ooki","year":"2021","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.toxicon.2025.108651_bib27","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1038\/aps.2012.72","article-title":"PI3K and Akt as molecular targets for cancer therapy: current clinical outcomes","volume":"33","author":"Pal","year":"2012","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.toxicon.2025.108651_bib28","doi-asserted-by":"crossref","first-page":"7527","DOI":"10.12659\/MSM.918431","article-title":"C(1)(8)H(1)(7)NO(6) inhibits invasion and migration of human MNNG osteosarcoma cells via the PI3K\/AKT signaling pathway","volume":"25","author":"Qu","year":"2019","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.toxicon.2025.108651_bib29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1758-2946-6-13","article-title":"TCMSP: a database of systems pharmacology for drug discovery from herbal medicines","volume":"6","author":"Ru","year":"2014","journal-title":"J. Cheminf."},{"key":"10.1016\/j.toxicon.2025.108651_bib30","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.toxicon.2025.108651_bib31","doi-asserted-by":"crossref","first-page":"viii354","DOI":"10.1093\/annonc\/mdy285.201","article-title":"Role of FGFR2 amplification in prognosis of patients with ovarian cancer","volume":"29","author":"Tyulyandina","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.toxicon.2025.108651_bib32","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1080\/13543784.2019.1672655","article-title":"Investigational fibroblast growth factor receptor 2 antagonists in early phase clinical trials to treat solid tumors","volume":"28","author":"Wang","year":"2019","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.toxicon.2025.108651_bib33","article-title":"Origins, phytochemistry, pharmacology, analytical methods and safety of cortex Moutan (Paeonia suffruticosa Andrew): a systematic review","volume":"22","author":"Wang","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.toxicon.2025.108651_bib34","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/jphp.13204","article-title":"Paeoniflorin: a monoterpene glycoside from plants of Paeoniaceae family with diverse anticancer activities","volume":"72","author":"Xiang","year":"2020","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.toxicon.2025.108651_bib35","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/jphp.13204","article-title":"Paeoniflorin: a monoterpene glycoside from plants of Paeoniaceae family with diverse anticancer activities","volume":"72","author":"Xiang","year":"2020","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.toxicon.2025.108651_bib36","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/COC.0000000000001088","article-title":"Advancements in NSCLC: from pathophysiological insights to targeted treatments","volume":"47","author":"Xu","year":"2024","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.toxicon.2025.108651_bib37","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1016\/j.ymthe.2020.07.003","article-title":"CRISPR-Cas12a with an oAd induces precise and cancer-specific genomic reprogramming of EGFR and efficient tumor regression","volume":"28","author":"Yoon","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.toxicon.2025.108651_bib38","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.1007\/s00210-024-02963-6","article-title":"Paeonol upregulates expression of tumor suppressors TNNC1 and SCARA5, exerting anti-tumor activity in non-small cell lung cancer cells","volume":"397","author":"Zhang","year":"2024","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.toxicon.2025.108651_bib39","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/s41586-022-05066-5","article-title":"Truncated FGFR2 is a clinically actionable oncogene in multiple cancers","volume":"608","author":"Zingg","year":"2022","journal-title":"Nature"}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004101012500426X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004101012500426X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T14:00:05Z","timestamp":1773324005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004101012500426X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":39,"alternative-id":["S004101012500426X"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2025.108651","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paeoniflorin suppresses non-small cell lung cancer by interrupting FGF2-FGFR2-PI3K axis","name":"articletitle","label":"Article Title"},{"value":"Toxicon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxicon.2025.108651","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108651"}}